David G. Mutch

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

10.5Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Pan-cancer analysis of whole genomes

Nature(2020)10.1038/s41586-020-1969-6

Top 3%

5.9DataRank

Top 3%3307 citations

Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Hiroyuki Aburatani, David J. Adams +1244 more

Papers

Driven by 42 papers — median percentile 96. Top paper: “Pan-cancer analysis of whole genomes”.

Pan-cancer analysis of whole genomes

Nature(2020)10.1038/s41586-020-1969-6

Top 3%

5.9DataRank

Top 3%3307 citations

Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Hiroyuki Aburatani, David J. Adams +1244 more

Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

Nature(2020)10.1038/s41586-020-1965-x

Top 5%

4.6DataRank

Top 5%668 citations

Federico Abascal, Jeremiah A. Wala, Ofer Shapira, Grace Tiao, Henrik Hornshøj +1240 more

Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.01.025

N/A

2.5DataRank · unranked

85 citations

Virginia L. Filiaci, Adrianne Mallen, Kristina W. Thiel, Eric J. Devor, Katherine Moxley +17 more

Integrated genomic analyses of ovarian carcinoma

Nature(2011)10.1038/nature10166

N/A

1.3DataRank · unranked

8094 citations

Debra Bell, Andrew Berchuck, Michael J. Birrer, Jeremy Chien, D. W. Cramer +268 more

Proteogenomic insights suggest druggable pathways in endometrial carcinoma

Cancer Cell(2023)10.1016/j.ccell.2023.07.007

N/A

1.2DataRank · unranked

54 citations

Lizabeth Katsnelson, Marina A. Gritsenko, Yingwei Hu, Boris Reva, Runyu Hong +95 more

Long-Term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response

Clinical Oncology(2021)10.1016/j.clon.2021.01.010

N/A

1.2DataRank · unranked

13 citations

Farrokh Dehdashti, L. Stewart Massad, Premal H. Thaker, Matthew A. Powell, David G. Mutch +5 more

Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup

Journal of Clinical Oncology(2009)10.1200/jco.2008.19.1684

N/A

0.984DataRank · unranked

706 citations

Mark F. Brady, William P. McGuire, Peter G. Harper, David S. Alberts, D. Ennis +13 more

The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women

Gynecologic Oncology(2021)10.1016/j.ygyno.2020.12.040

N/A

0.941DataRank · unranked

26 citations

Wei Deng, Richard J. Zaino, Matthew A. Powell, Camille C. Gunderson, Casey Cosgrove +15 more

Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259)

Journal of Clinical Oncology(2022)10.1200/jco.21.00656

N/A

0.848DataRank · unranked

23 citations

Susan M. Sereika, Lari Wenzel, Robert P. Edwards, Judith E. Knapp, Susan H. Hughes +13 more

Microscaled proteogenomic methods for precision oncology

Nature Communications(2020)10.1038/s41467-020-14381-2

N/A

0.722DataRank · unranked

122 citations

Eric J. Jaehnig, Karsten Krug, Beom‐Jun Kim, Alexander B. Saltzman, Doug W. Chan +28 more

Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study

Journal of Clinical Oncology(2024)10.1200/jco.23.02076

N/A

0.644DataRank · unranked

20 citations

Ronald J. Buckanovich, Michael W. Sill, Robert S. Mannel, Joan L. Walker, Paul DiSilvestro +13 more

A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Neoplasia

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2293

N/A

0.505DataRank · unranked

28 citations

Megan Othus, Young Kwang Chae, Michael J. Dennis, Sarah Gordon, David G. Mutch +9 more

The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.03.018

N/A

0.415DataRank · unranked

10 citations

William P. Tew, Christopher Purdy, S. Dennis, Andrew Menzin, John L. Lovecchio +16 more

Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.08.005

N/A

0.360DataRank · unranked

10 citations

Wei Deng, Richard J. Zaino, Matthew A. Powell, Camille Gunderson Jackson, Casey Cosgrove +14 more

Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous Cancer

Cancers(2021)10.3390/cancers13235877

N/A

0.312DataRank · unranked

7 citations

Elena Lomonosova, Shaina F. Bruce, Joan Tankou, Mary M. Mullen, Angela M. Schab +12 more

Gynecologic oncology patient perspectives and knowledge on advance care planning: A quality improvement intervention

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.101060

N/A

0.208DataRank · unranked

3 citations

Sophia Lewis, Mark C. Valentine, M. Palisoul, Premal H. Thaker, Andrea R. Hagemann +6 more

Author Correction: Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis

Communications Biology(2022)10.1038/s42003-022-03769-z

N/A

0.165DataRank · unranked

2 citations

Lars Feuerbach, Chen Hong, David Mas-Ponte, Randi Istrup Pedersen, PCAWG Drivers and Functional Interpretation Group +1255 more

Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.05.013

N/A

0.104DataRank · unranked

1 citations

Austin Miller, Judith A. Smith, Stuart M. Lichtman, Michael A. Bookman, Carol Aghajanian +17 more

Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiation

International Journal of Gynecological Cancer(2024)10.1136/ijgc-2024-005303

N/A

0DataRank · unranked

8 citations

Surbhi Grover, Yi Huang, Premal H. Thaker, Lindsay M. Kuroki, Matthew A. Powell +6 more

Microscaled proteogenomic methods for precision oncology

UNC Libraries(2024)10.17615/rb11-7v56

N/A

0DataRank · unranked

0 citations

B Zhang, F. O. Ademuyiwa, Prashant R. Singh, Charles M. Perou, Alexander B. Saltzman +28 more

Enhancing Progestin Therapy with a Glucagon-Like Peptide 1 Agonist for the Conservative Management of Endometrial Cancer

Cancers(2025)10.3390/cancers17040598

N/A

0DataRank · unranked

14 citations

Ian S. Hagemann, David G. Mutch, Eric J. Devor, Paige K. Malmrose, Yuping Zhang +4 more

Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination–proficient ovarian cancer

Journal of Clinical Investigation(2025)10.1172/jci189511

N/A

0DataRank · unranked

7 citations

Amanda Compadre, Rebecca Drexler, Megan Loeb, Kevin Rodriguez, Joshua Brill +22 more

Multi-center, international endometrial cancer consortium highlights

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2025.101805

N/A

0DataRank · unranked

3 citations

Anna Giudici, Vincenzo Tarantino, Stuart A. Ostby, Kelly H. Bruce, Daniel M. Breitkopf +28 more

Integration of a lifestyle modification intervention for women with overweight and obesity in a gynecologic oncology practice

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.04.516

N/A

0DataRank · unranked

4 citations

Alison Kosmacki, Leah Tolby, Christine Marx, Jessica Vanderlan, David G. Mutch +3 more

Targeting RAD52 overcomes PARP inhibitor resistance in preclinical Brca2 -deficient ovarian cancer model

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.24.678351

N/A

0DataRank · unranked

0 citations

Vijayalaxmi Gupta, Bisiayo Fashemi, Moreniola Akande, Elizabeth Babu, Prasanth Thuthika +17 more

Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower

Nature Communications(2022)10.1038/s41467-022-32343-8

N/A

0DataRank · unranked

0 citations

PCAWG Drivers and Functional Interpretation Working Group, Federico Abascal, Samirkumar B. Amin, Pratiti Bandopadhayay, Rameen Beroukhim +1242 more

Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence

UNC Libraries(2020)10.17615/4pe6-bb70

N/A

0DataRank · unranked

2 citations

Kay J. Park, David G. Mutch, Shashikant B. Lele, Louise A. Brinton, Shamshad Ali +14 more

Effect on response to neoadjuvant chemotherapy in high-grade serous ovarian cancer by inhibiting the GAS6/AXL pathway and inducing homologous recombination deficiency.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6080

N/A

0DataRank · unranked

0 citations

Elena Lomonosova, Michael Toboni, Hollie Noia, Danny Wilke, Alyssa Oplt +9 more

Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol

UNC Libraries(2020)10.17615/5jcw-ca69

N/A

0DataRank · unranked

0 citations

David S. Miller, Steven Waggoner, Robert P. Edwards, Saketh R. Guntupalli, Matthew A. Powell +13 more

A deficit-accumulation frailty index predicts survival outcomes in patients with gynecologic malignancy

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.02.027

N/A

0DataRank · unranked

15 citations

Tyler McKinnish, Mark A. Fiala, Abigail Zamorano, Lindsay M. Kuroki, Katherine C. Fuh +7 more

Impact of employment and insurance status on distress in gynecologic oncology patients

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.01.038

N/A

0DataRank · unranked

10 citations

David H. Morris, Molly M. Greenwade, Megan Landon, Andrea R. Hagemann, Premal H. Thaker +8 more

Radiation therapy for vaginal and perirectal lesions in recurrent ovarian cancer

Gynecologic Oncology Reports(2021)10.1016/j.gore.2021.100808

N/A

0DataRank · unranked

3 citations

Jennifer Stanley, Michael Toboni, Julie K. Schwarz, F. Zhang, Andrea R. Hagemann +8 more

GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0704

N/A

0DataRank · unranked

16 citations

Kevin Cho, Hollie Noia, Elena Lomonosova, Elizabeth Stock, Alyssa Oplt +13 more

Quantification of ovarian lesion and fallopian tube vasculature using optical-resolution photoacoustic microscopy

Scientific Reports(2022)10.1038/s41598-022-19778-1

N/A

0DataRank · unranked

7 citations

Sitai Kou, Yixiao Lin, Andrea R. Hagemann, Ian S. Hagemann, Premal H. Thaker +7 more

The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer

BMC Cancer(2022)10.1186/s12885-022-09367-w

N/A

0DataRank · unranked

4 citations

Yassar M. Hashim, J.C. Cripe, Tommy Buchanan, Abigail Zamorano, Suwanna Vangveravong +5 more

Community access to primary care is an important geographic disparity among ovarian cancer patients undergoing cytoreductive surgery

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.101075

N/A

0DataRank · unranked

1 citations

Angela L. Mazul, Christine Marx, Mary M. Mullen, Molly M. Greenwade, L. Stewart Massad +9 more

A phase I/II study of ruxolitinib with frontline neoadjuvant and post-surgical therapy in patients with advanced epithelial ovarian, Fallopian tube, or primary peritoneal cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.5501

N/A

0DataRank · unranked

9 citations

Ronald J. Buckanovich, Michael W. Sill, Robert S. Mannel, Joan L. Walker, Paul DiSilvestro +13 more

The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer

Research Square(2022)10.21203/rs.3.rs-1153043/v1

N/A

0DataRank · unranked

0 citations

Yassar M. Hashim, J.C. Cripe, Tommy Buchanan, Abigail Zamorano, Suwanna Vangveravong +5 more

1469 A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART SWOG 1609 Cohort 47) in patients with gestational trophoblastic disease

(2022)10.1136/jitc-2022-sitc2022.1469

N/A

0DataRank · unranked

0 citations

Megan Othus, Young Kwang Chae, Michael J. Dennis, Sarah Gordon, David G. Mutch +7 more

RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3335

N/A

0DataRank · unranked

65 citations

Lillian N. van Biljon, Mark C. Valentine, Alba Llop‐Guevara, Emily Graham, Bisiayo Fashemi +18 more

Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins

Molecular Cancer Research(2023)10.1158/1541-7786.mcr-23-0347

N/A

0DataRank · unranked

22 citations

Molly M. Greenwade, Elizabeth Stock, Elena Lomonosova, Kevin Cho, Whitney R. Grither +17 more

Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O‐RADS risk assessment

Ultrasound in Obstetrics and Gynecology(2023)10.1002/uog.27452

N/A

0DataRank · unranked

3 citations

Hongbo Luo, William D. Middleton, Malak Itani, Ian S. Hagemann, Andrea R. Hagemann +8 more

David G. Mutch

Indexed papers

Top data-sharing exemplar

Papers